Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, June 20, 2013
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Bringing Out the Usual – and Unusual – Cancer Genomics Suspects
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.
DNA-Altering Enzyme is Essential for Blood Cell Development
The expression of specific genes is partially dictated by the way the DNA is packed into chromatin, a tightly packed combination of DNA and proteins known as histones.
DNA Sequencing Reveals Mucosal Melanoma's Bullseye
Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment.
Studies Illuminate Functions of RNA
Researchers at the University of California illuminate the functional importance of a relatively new class of RNA molecules.
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Mouse Study Suggests Lead May Trigger Schizophrenia
Behavioral and MRI study in mice points to a synergistic relationship between lead exposure and schizophrenia gene.
Identified a Key Protein in Maintaining the Identity of B Lymphocytes
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.
Gene Mutation Gives Boost to Brain Cancer Cells
An international team of researchers has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly.
Potential New Way to Suppress Tumor Growth Discovered
The new mechanism opens up the possibility of developing a new class of anti-cancer drugs.
Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis
Finding could lead to earlier diagnosis and new, more aggressive treatment for worst cases.

Exploratory Pharmacogenetic Analysis of Efalizumab Responders
Emmanuel Monnet, Head of Biomarker, Merck Serono, speaking at Molecular Diagnostics World Congress 2009

Clinically Actionable Proteomic Biomarkers in Rheumatoid Arthritis
Bill Robinson, Assistant Professor, Stanford University, speaking at Microarray World Congress 2009

New Approaches to Biomarker Detection
John Park, Founder, Nanosurface Biosciences, speaking at Microarray World Congress 2009

Challenges in the Development of Tissue Biomarkers
Steven Hewitt, Chief, Tissue Array Research Program, National Cancer Institute, Maryland, speaking at Microarray World Congress 2009

Chemogenomics: Medicinal Chemistry Meets Pharmacology at a Genome Scale
Jordi Mestres, Head Chemogenomics Lab, Universitat Pompeu Fabra, speaking at MedChem Europe 2009

Enabling Personalised Medicine From FFPE Tissue
Austin Tanney, Scientific Liaison Manager, Almac, speaking at Molecular Diagnostics Europe 2009

Advancing Drug Discovery in an Academic Setting
Julie Frearson, Professor Biotechnology/Drug Discovery/Biological Chemistry and Molecular Pharmacology, University of Dundee, speaking at Screening Europe 2009

De Novo Molecular Design: A Powerful Strategy for the Discovery of New Potential Antimalarials and Antibacterials
Colin Fishwick, Reader/ Director Organic Chemistry/Leeds Structure-Based Drug Design Group, University of Leeds School of Chemistry, speaking at MedChem Europe 2009

CYP Poor Metaboliser Genotyping on the Agilent Bioanalyzer and Clinical Application
Irina Piatkov, Senior Hospital Scientist, Diversity Health Institute, speaking at the Molecular Diagnostics World Congress 2009

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 105
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to ePosters.net